Redmile Group

Fiche investisseur | Builders Republic

À propos

Redmile Group is a global healthcare investment firm focused on life sciences, investing across both private (venture/growth) and public markets in biotech, medtech, and health technology, with a crossover approach and long‑term, research‑driven strategy.

Informations clés

Type
IM / Cross-over Fund
Stades
Series A,Series B,Growth,Pre-IPO,Listed
Secteurs
Healthcare,Biotech,Medtech,Diagnostics,Digital health
Siège
US
Bureaux
San Francisco,New York
Focus géographique
France,Europe,USA
Lead / Follow
Can lead and follow
Fondé en
2007

Investissements notables en France

One Biosciences, Home Biosciences, Mnemo Therapeutics

Points différenciants

Sector Specialist,Transatlantic footprint